Hadas Shoham Nissan, Director Clinical and Regulatory affairs

With over 15 years of experience in cell and gene therapy, spanning clinical, regulatory, and business aspects. Previously with Emendo and Gamida Cell (NASDAQ: GMDA), she holds an M.Sc. in Medical Research and an M.B.A. in Finance & Marketing from the Hebrew University.